Positive leronlimab treatment in critically Ill COVID-19 patient published
On Mar. 23, 2021, CytoDyn announced the publication in the Journal of Translational Autoimmunity ‘Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab.’
The FDA had granted a Fast Track designation to CytoDyn for two potential indications of leronlimab for critical illnesses.
Tags:
Source: National Library of Medicine
Credit:
